Inventiva (IVA) Retained Earnings (2018 - 2025)
Inventiva (IVA) posted quarterly Retained Earnings of -$3.2 million for Q4 2025, down 174.58% year-over-year from $4.3 million in Q4 2024, and up 100.0% quarter-over-quarter from -$239.4 billion in Q2 2025.
Inventiva (IVA) Retained Earnings (2018 - 2025) Analysis & Trends
Inventiva's Retained Earnings history runs 8 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 174.58% year-over-year to -$3.2 million; the TTM figure through Dec 2025 stood at -$3.2 million (down 174.58% YoY), while the FY2025 annual figure was -$3.2 million, down 174.58% from the prior year.
- Retained Earnings for Q4 2025 stood at -$3.2 million, up from -$239.4 billion in the prior quarter.
- The five-year high for Retained Earnings was -$190842.4 in Q4 2023, with the low at -$239.4 billion in Q2 2025.
- The 5-year median for Retained Earnings is -$18.7 million (2025), against an average of -$35.0 billion.
- Peak annual rise in Retained Earnings reached 174.58% in 2025, while the deepest fall reached 21839761.57% in 2025.
- Inventiva's Retained Earnings stood at -$30.7 billion in 2021, then slumped by 160.48% to -$79.9 billion in 2022, then surged by 100.0% to -$191517.3 in 2023, then tumbled by 507.62% to -$1.2 million in 2024, then sank by 174.58% to -$3.2 million in 2025.
- Business Quant data shows IVA's Retained Earnings at -$3.2 million in Q4 2025, -$239.4 billion in Q2 2025, and -$1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | -3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.20 Mn |
| Jun 30, 2025 | -239.42 Bn |
| Dec 31, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.10 Mn |
| Dec 31, 2023 | -191,517.30 |
| Oct 11, 2023 | -190,842.37 |
| Jun 30, 2022 | -79.90 Bn |
| Dec 31, 2021 | -30.68 Bn |
| Jun 30, 2021 | -34.19 Mn |
| Mar 31, 2021 | -34.93 Mn |
| Dec 31, 2020 | 5.70 Mn |
| Dec 31, 2019 | -33.45 Mn |
| Dec 31, 2018 | -37.68 Mn |